Skip to main content

Peer Review reports

From: Low-dose nivolumab in advanced hepatocellular carcinoma

Original Submission
3 Aug 2022 Submitted Original manuscript
25 Aug 2022 Reviewed Reviewer Report
27 Aug 2022 Reviewed Reviewer Report
11 Sep 2022 Author responded Author comments - Yen-Hao Chen
14 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 2
11 Sep 2022 Submitted Manuscript version 2
Publishing
2 Nov 2022 Editorially accepted
8 Nov 2022 Article published 10.1186/s12885-022-10271-6

You can find further information about peer review here.

Back to article page